Longwood Capital Partners

Acuta Capital Partners as of June 30, 2024

Portfolio Holdings for Acuta Capital Partners

Acuta Capital Partners holds 33 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ocular Therapeutix (OCUL) 16.0 $19M 2.8M 6.84
Enliven Therapeutics (ELVN) 7.8 $9.3M 398k 23.37
Vaxcyte (PCVX) 7.0 $8.3M 110k 75.51
Dyne Therapeutics (DYN) 6.3 $7.5M 213k 35.29
Praxis Precision Medicines I (PRAX) 5.7 $6.8M 164k 41.36
Crinetics Pharmaceuticals In (CRNX) 5.1 $6.1M 135k 44.79
Rocket Pharmaceuticals (RCKT) 4.5 $5.4M 250k 21.53
Taysha Gene Therapies Com Shs (TSHA) 4.4 $5.2M 2.3M 2.24
Revolution Medicines (RVMD) 4.3 $5.2M 133k 38.81
Insmed Com Par $.01 (INSM) 4.1 $4.8M 72k 67.00
Sarepta Therapeutics (SRPT) 3.7 $4.3M 28k 158.00
Tourmaline Bio (TRML) 2.9 $3.5M 270k 12.86
Agios Pharmaceuticals (AGIO) 2.9 $3.4M 79k 43.12
Kura Oncology (KURA) 2.8 $3.4M 163k 20.59
Mersana Therapeutics (MRSN) 2.8 $3.3M 1.7M 2.01
Corbus Pharmaceuticals Holdi Com New (CRBP) 2.5 $2.9M 65k 45.25
Aadi Bioscience (AADI) 2.3 $2.7M 1.8M 1.46
Miragen Therapeutics (VRDN) 2.2 $2.6M 199k 13.01
Terns Pharmaceuticals (TERN) 2.1 $2.5M 369k 6.81
Mereo Biopharma Group Pl- Spon Ads (MREO) 2.1 $2.4M 677k 3.60
Arcellx Common Stock (ACLX) 2.0 $2.3M 42k 55.19
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) 1.5 $1.8M 178k 10.22
Argenx Se Sponsored Adr (ARGX) 1.4 $1.7M 4.0k 430.04
Trevi Therapeutics (TRVI) 0.7 $775k 260k 2.98
Celcuity (CELC) 0.6 $737k 45k 16.38
Oric Pharmaceuticals (ORIC) 0.6 $679k 96k 7.07
Pliant Therapeutics (PLRX) 0.4 $497k 46k 10.75
Rapport Therapeutics (RAPP) 0.4 $465k 20k 23.26
Newamsterdam Pharma Co Nv Ordinary Shares (NAMS) 0.4 $432k 23k 19.21
Leap Therapeutics Com New (LPTX) 0.3 $382k 195k 1.96
Cellectar Biosciences Com New (CLRB) 0.1 $176k 71k 2.50
Savara Put Option (SVRA) 0.1 $101k 250.00 403.00
Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) 0.0 $15k 91k 0.16